{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T13:05:17Z","timestamp":1792501517295,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.yebeh.2019.02.005","type":"journal-article","created":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T13:20:50Z","timestamp":1555334450000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["EEG changes in patients on antipsychotic therapy: A systematic review"],"prefix":"10.1016","volume":"95","author":[{"given":"Anvesh","family":"Jackson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udaya","family":"Seneviratne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.yebeh.2019.02.005_bb0005","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/0004867416641195","article-title":"Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders","volume":"50","author":"Galletly","year":"2016","journal-title":"Aust N Z J Psychiatry"},{"issue":"12","key":"10.1016\/j.yebeh.2019.02.005_bb0010","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1177\/0004867415617657","article-title":"Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders","volume":"49","author":"Malhi","year":"2015","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.yebeh.2019.02.005_bb0015","series-title":"Future research needs for first- and second-generation antipsychotics for children and young adults","volume":"13","author":"Christian","year":"2012"},{"key":"10.1016\/j.yebeh.2019.02.005_bb0020","series-title":"Clinical practice guidelines and principles of care for people with dementia in Australia","author":"Guideline Adaptation Committee","year":"2016"},{"key":"10.1016\/j.yebeh.2019.02.005_bb0025","first-page":"1163","article-title":"Clinical pharmacology of atypical antipsychotics: an update","volume":"13","author":"Mauri","year":"2014","journal-title":"EXCLI J"},{"issue":"6","key":"10.1016\/j.yebeh.2019.02.005_bb0030","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00002018-199309060-00005","article-title":"Adverse effects of antipsychotic drugs","volume":"9","author":"Malhotra","year":"1993","journal-title":"Drug Saf"},{"issue":"4","key":"10.1016\/j.yebeh.2019.02.005_bb0035","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1177\/0269881114562090","article-title":"\u201cFirst do no harm.\u201d A systematic review of the prevalence and management of antipsychotic adverse effects","volume":"29","author":"Young","year":"2015","journal-title":"J Psychopharmacol"},{"issue":"5","key":"10.1016\/j.yebeh.2019.02.005_bb0040","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1503\/cmaj.061250","article-title":"Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients","volume":"176","author":"Schneeweiss","year":"2007","journal-title":"CMAJ"},{"issue":"7489","key":"10.1016\/j.yebeh.2019.02.005_bb0045","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1136\/bmj.38330.470486.8F","article-title":"Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study","volume":"330","author":"Gill","year":"2005","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.yebeh.2019.02.005_bb0050","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1046\/j.1528-1157.2001.17101.x","article-title":"Significance of epileptiform discharges in patients without epilepsy in the community","volume":"42","author":"Sam","year":"2001","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.yebeh.2019.02.005_bb0055","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/1039856213502829","article-title":"Use of anticonvulsants as prophylaxis for seizures in patients on clozapine","volume":"22","author":"Caetano","year":"2014","journal-title":"Australas Psychiatry"},{"key":"10.1016\/j.yebeh.2019.02.005_bb0060","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.yebeh.2019.02.005_bb0065","author":"The Cochrane Public Health Group"},{"key":"10.1016\/j.yebeh.2019.02.005_bb0070","first-page":"21","article-title":"A glossary of terms most commonly used by clinical electroencephalographers and proposal for the report form for the EEG findings. The International Federation of Clinical Neurophysiology","volume":"52","author":"Noachtar","year":"1999","journal-title":"Electroencephalogr Clin Neurophysiol Suppl"},{"key":"10.1016\/j.yebeh.2019.02.005_bb0075","series-title":"Joanna Briggs Institute Reviewer's Manual","article-title":"Chapter 3: systematic reviews of effectiveness","author":"Tufanaru","year":"2017"},{"issue":"7414","key":"10.1016\/j.yebeh.2019.02.005_bb0080","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.yebeh.2019.02.005_bb0085","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0013-4694(58)90040-3","article-title":"The effect of orally administered chlorpromazine on the electroencephalogram of man","volume":"10","author":"Jorgensen","year":"1958","journal-title":"Electroencephalogr Clin Neurophysiol"},{"issue":"1","key":"10.1016\/j.yebeh.2019.02.005_bb0090","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/155005947800900105","article-title":"Validity and clinical utility of neuroleptic-facilitated electroencephalography in psychotic patients","volume":"9","author":"Neil","year":"1978","journal-title":"Clin Electroencephalogr"},{"issue":"1","key":"10.1016\/j.yebeh.2019.02.005_bb0095","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1176\/appi.ajp.159.1.109","article-title":"EEG abnormalities during treatment with typical and atypical antipsychotics","volume":"159","author":"Centorrino","year":"2002","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.yebeh.2019.02.005_bb0100","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0278-5846(01)00238-X","article-title":"A retrospective study of clozapine and electroencephalographic abnormalities in schizophrenic patients","volume":"26","author":"Chung","year":"2002","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.yebeh.2019.02.005_bb0105","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.2147\/NDT.S69784","article-title":"Clozapine-induced seizures, electroencephalography abnormalities, and clinical responses in Japanese patients with schizophrenia","volume":"10","author":"Kikuchi","year":"2014","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"3","key":"10.1016\/j.yebeh.2019.02.005_bb0110","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0013-4694(94)90070-1","article-title":"Spectrum of EEG abnormalities during clozapine treatment","volume":"91","author":"Malow","year":"1994","journal-title":"Electroencephalogr Clin Neurophysiol"},{"issue":"2","key":"10.1016\/j.yebeh.2019.02.005_bb0115","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0924-977X(95)00057-V","article-title":"EEG abnormalities in clozapine-treated schizophrenic patients","volume":"6","author":"Treves","year":"1996","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"10.1016\/j.yebeh.2019.02.005_bb0120","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00002826-199619010-00007","article-title":"Electroencephalographic findings with low-dose clozapine treatment in psychotic Parkinsonian patients","volume":"19","author":"Neufeld","year":"1996","journal-title":"Clin Neuropharmacol"},{"issue":"4","key":"10.1016\/j.yebeh.2019.02.005_bb0125","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1176\/jnp.7.4.466","article-title":"Clozapine-induced EEG abnormalities and clinical response to clozapine","volume":"7","author":"Risby","year":"1995","journal-title":"J Neuropsychiatr Clin Neurosci"},{"issue":"1","key":"10.1016\/j.yebeh.2019.02.005_bb0130","first-page":"30","article-title":"Electroencephalographic abnormality and clinical response in patients with first-episode schizophrenia treated with clozapine","volume":"15","author":"Shrivastava","year":"2014","journal-title":"ASEAN J Psychiatry"},{"issue":"10","key":"10.1016\/j.yebeh.2019.02.005_bb0135","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1176\/ajp.148.10.1406b","article-title":"EEG abnormalities associated with clozapine treatment","volume":"148","author":"Tiihonen","year":"1991","journal-title":"Am J Psychiatry"},{"issue":"7","key":"10.1016\/j.yebeh.2019.02.005_bb0140","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00406-011-0208-4","article-title":"EEG alterations during treatment with olanzapine","volume":"261","author":"Degner","year":"2011","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"3","key":"10.1016\/j.yebeh.2019.02.005_bb0145","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/104454603322572642","article-title":"Olanzapine treatment in chronic drug-resistant childhood-onset schizophrenia: an open-label study","volume":"13","author":"Mozes","year":"2003","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"1\u20132","key":"10.1016\/j.yebeh.2019.02.005_bb0150","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF00431718","article-title":"An open study of remoxipride, a benzamide derivative, in schizophrenia","volume":"86","author":"Lindstr\u00f6m","year":"1985","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1016\/j.yebeh.2019.02.005_bb0155","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1111\/j.1528-1167.2008.02001.x","article-title":"EEG features of absence seizures in idiopathic generalized epilepsy: impact of syndrome, age, and state","volume":"50","author":"Sadleir","year":"2009","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.yebeh.2019.02.005_bb0160","first-page":"3","article-title":"Electroencephalography in the elderly","volume":"52","author":"Davidson","year":"2012","journal-title":"Neurodiagn J"},{"issue":"1","key":"10.1016\/j.yebeh.2019.02.005_bb0165","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-2003-40750","article-title":"Pearls, perils, and pitfalls in the use of the electroencephalogram","volume":"23","author":"Markand","year":"2003","journal-title":"Semin Neurol"},{"issue":"2","key":"10.1016\/j.yebeh.2019.02.005_bb0170","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/2045125311405566","article-title":"Clozapine-related EEG changes and seizures: dose and plasma-level relationships","volume":"1","author":"Varma","year":"2011","journal-title":"Ther Adv Psychopharmacol"},{"issue":"1-02","key":"10.1016\/j.yebeh.2019.02.005_bb0175","first-page":"9","article-title":"Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017","volume":"51","author":"Hiemke","year":"2018","journal-title":"Pharmacopsychiatry"},{"issue":"9","key":"10.1016\/j.yebeh.2019.02.005_bb0180","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1016\/j.clinph.2016.06.019","article-title":"The ambiguous relationship between spikes and seizures","volume":"127","author":"Abou-Khalil","year":"2016","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.yebeh.2019.02.005_bb0185","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/brain\/aww019","article-title":"Interictal spikes and epileptic seizures: their relationship and underlying rhythmicity","volume":"139","author":"Karoly","year":"2016","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.yebeh.2019.02.005_bb0190","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1016\/j.clinph.2016.05.014","article-title":"The relationship between seizures, interictal spikes and antiepileptic drugs","volume":"127","author":"Goncharova","year":"2016","journal-title":"Clin Neurophysiol"},{"issue":"2\u20133","key":"10.1016\/j.yebeh.2019.02.005_bb0195","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.schres.2005.10.021","article-title":"Clinical significance of sleep EEG abnormalities in chronic schizophrenia","volume":"82","author":"Yang","year":"2006","journal-title":"Schizophr Res"},{"key":"10.1016\/j.yebeh.2019.02.005_bb0200","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2147\/NSS.S121076","article-title":"Schizophrenia and sleep disorders: links, risks, and management challenges","volume":"9","author":"Kaskie","year":"2017","journal-title":"Nat Sci Sleep"},{"key":"10.1016\/j.yebeh.2019.02.005_bb0205","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3389\/fneur.2017.00499","article-title":"Electroencephalography in the diagnosis of genetic generalized epilepsy syndromes","volume":"8","author":"Seneviratne","year":"2017","journal-title":"Front Neurol"},{"issue":"4","key":"10.1016\/j.yebeh.2019.02.005_bb0210","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1528-1157.1970.tb03903.x","article-title":"Factors related to the occurrence of typical paroxysmal abnormalities in the EEG records of epileptic patients","volume":"11","author":"Marsan","year":"1970","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.yebeh.2019.02.005_bb0215","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1528-1167.2011.03344.x","article-title":"The electroencephalogram of idiopathic generalized epilepsy","volume":"53","author":"Seneviratne","year":"2012","journal-title":"Epilepsia"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505018310412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505018310412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:27:21Z","timestamp":1761503241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505018310412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":43,"alternative-id":["S1525505018310412"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2019.02.005","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EEG changes in patients on antipsychotic therapy: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2019.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}